Cargando…
Virus-Induced CD8(+) T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
The current battle against Severe Acute Respiratory Syndrome (SARS)-Coronavirus-2 benefits from the worldwide distribution of different vaccine formulations. All anti-SARS-CoV-2 vaccines in use are conceived to induce anti-Spike neutralizing antibodies. However, this strategy still has unresolved is...
Autor principal: | Federico, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402519/ https://www.ncbi.nlm.nih.gov/pubmed/34452047 http://dx.doi.org/10.3390/vaccines9080922 |
Ejemplares similares
-
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020) -
Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022) -
SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020) -
Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021) -
Physician requirements for adoption of telehealth following the SARS-CoV-2 pandemic
por: Hodgkins, Michael, et al.
Publicado: (2021)